Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tandem Diabetes Care (TNDM)

Tandem Diabetes Care (TNDM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,912,830
  • Shares Outstanding, K 60,906
  • Annual Sales, $ 362,310 K
  • Annual Income, $ -24,750 K
  • 60-Month Beta 0.50
  • Price/Sales 18.93
  • Price/Cash Flow N/A
  • Price/Book 25.62
Trade TNDM with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.08
  • Number of Estimates 8
  • High Estimate 0.05
  • Low Estimate -0.18
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +38.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
102.16 +10.94%
on 09/17/20
116.89 -3.04%
on 09/02/20
-2.75 (-2.37%)
since 09/01/20
3-Month
91.93 +23.29%
on 07/14/20
116.89 -3.04%
on 09/02/20
+14.46 (+14.62%)
since 07/01/20
52-Week
43.69 +159.42%
on 03/18/20
116.89 -3.04%
on 09/02/20
+57.36 (+102.47%)
since 10/01/19

Most Recent Stories

More News
Insulet (PODD) Hits a New 52-Week High: What's Driving It?

Insulet (PODD) is optimistic about maintaining growth momentum of its Omnipod system along with tapping the booming diabetes market.

MDT : 103.31 (-0.59%)
QGEN : 53.17 (+1.74%)
PODD : 237.29 (+0.30%)
TNDM : 113.27 (-0.20%)
3 Stocks to Buy From Strong MedTech Spaces Amid the Pandemic

Here are three stocks from three sub-sectors from MedTech that have held their ground despite the pandemic-led market mayhem.

SRDX : 38.56 (-0.90%)
RMD : 169.84 (-0.93%)
QGEN : 53.17 (+1.74%)
HCA : 123.82 (-0.69%)
TNDM : 113.27 (-0.20%)
4 Best Diabetes Device Stocks to Focus on Amid Coronavirus Crisis

Here are a few diabetes-centric MedTech stocks that investors can focus on to reap profits amid the pandemic-battered stock market situation.

MDT : 103.31 (-0.59%)
DXCM : 414.43 (+0.53%)
ABT : 109.64 (+0.74%)
PODD : 237.29 (+0.30%)
TNDM : 113.27 (-0.20%)
Medicare Coverage for Libre 2 Boosts Abbott's CGM Prospects

Abbott's (ABT) FreeStyle Libre 2 iCGM is now available to Medicare-eligible diabetic patients via CMS' reimbursement expansion.

HOLX : 66.56 (+0.14%)
QGEN : 53.17 (+1.74%)
ABT : 109.64 (+0.74%)
TNDM : 113.27 (-0.20%)
Tandem Diabetes Care Announces Upcoming Webcast Conference Presentations

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present a company...

MHMNF : 54.5000 (unch)
MS : 48.04 (-0.64%)
WFC : 23.46 (-0.21%)
TNDM : 113.27 (-0.20%)
Tandem Diabetes' Advanced Insulin Pump Study Results Favorable

Per the DCLP5 study, Tandem Diabetes' (TNDM) insulin pump with Control-IQ technology suitable for use in children aged six to 13 years, which has been published in the NEJM.

MDT : 103.31 (-0.59%)
QGEN : 53.17 (+1.74%)
ABT : 109.64 (+0.74%)
TNDM : 113.27 (-0.20%)
SmarTrend Watching for Potential Pullback in Shares of Tandem Diabetes After 4.43% Gain

Tandem Diabetes (NASDAQ:TNDM) traded in a range yesterday that spanned from a low of $106.01 to a high of $112.82. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high...

TNDM : 113.27 (-0.20%)
Tandem Diabetes Care Announces NEJM Publication of Pediatric Study Demonstrating Increased Time-In-Range using the t:slim X2 Insulin Pump with Control-IQ Technology

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by the New England Journal of Medicine (NEJM) of results from the Protocol...

TNDM : 113.27 (-0.20%)
Four UPGRADED Stocks to Buy Now!

The POWR Ratings upgrades and downgrades stocks every day. Sorting through these upgrades and downgrades can take time. Here are four top recently upgraded stocks: Workday (WDAY), TAL Education Group (TAL),...

WDAY : 219.99 (+2.26%)
TAL : 76.95 (+1.20%)
TNDM : 113.27 (-0.20%)
TENB : 38.54 (+2.09%)
SmarTrend Watching for Potential Pullback in Shares of Tandem Diabetes After 2.09% Gain

Tandem Diabetes (NASDAQ:TNDM) traded in a range yesterday that spanned from a low of $102.10 to a high of $105.32. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high...

TNDM : 113.27 (-0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Tandem Diabetes Care, Inc. is a medical device company. The Company designs, develops, and commercializes products for people with insulin-dependent diabetes. Its products include t:slim Insulin Delivery System. Tandem Diabetes Care, Inc. is headquartered in San Diego, California.

See More

Key Turning Points

2nd Resistance Point 116.53
1st Resistance Point 115.01
Last Price 113.27
1st Support Level 112.17
2nd Support Level 110.85

See More

52-Week High 116.89
Last Price 113.27
Fibonacci 61.8% 88.93
Fibonacci 50% 80.29
Fibonacci 38.2% 71.65
52-Week Low 43.69

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar